OutSee selected for Discovery Award from Longitude Prize on ALS to accelerate AI-based target discovery

Funding to identify novel targets for ALS treatment using OutSee’s ‘genomics first’ target discovery platform, NomalyProvides access to world’s largest and most comprehensive ALS patient datasetPart of £7.5M global challenge prize to leverage innovatio

Cyclana Bio granted Health Research Authority approval and recruits first patients for clinical observational study in endometriosis

UK NHS grants HRA/REC approval for PEMP study with Peterborough and Cambridge hospitalsClinical observational study investigating underlying biology of endometriosis aims to uncover causal mechanisms and new druggable targets to improve treatment outcomes 

Qureight to support Mediar Therapeutics’ Phase 2 trial of MTX-474 in diffuse cutaneous Systemic Sclerosis

Qureight’s AI-powered quantitative imaging analytics platform and services to analyse HRCT images to evaluate changes in compartment-specific lung biomarkersThe focus of these efforts will be on the quantitative assessment of change from baseline in lung fibrosis

Enterprise Therapeutics achieves primary efficacy outcome in Phase 2 clinical trial for cystic fibrosis with novel inhaled ENaC blocker ETD001

First investigational inhaled ENaC blocker to deliver clinically relevant and statistically significant change in lung function compared to placebo Inhaled therapeutic designed to treat the 10% of people with cystic fibrosis with the highest unmet medical need

Calla Lily Clinical Care doses first patients in clinical trial for intravaginal drug delivery platform for threatened miscarriage

FREEDOM study to evaluate progesterone delivery using Callavid intravaginal platformNIHR-funded trial in collaboration with University Hospitals Coventry and Warwickshire NHS Trust

London, UK, 06 May 2026: Calla Lily Clinical Care, a wo

FUJIFILM Biosciences and NextCell launch new commercial platform comprised of RUO Stromal Cells and Cell Culture Media

Collaboration results in platform to help researchers overcome challenges in MSC research

Bio-Rad expands range of TrailBlazer Kits for Antibody Conjugation to StarBright Dyes

Expanded Range Increases Access to Bio-Rad’s StarBright™ Dyes for Flow Cytometry and Western Blot Applications in Immunology Research

Qureight establishes Scientific Advisory Board focused on pulmonary hypertension

 

Lab Thread introduces Unified Lab Software Platform to streamline biological research

Connects scientific teams, data and workflows within a single, fully integrated digital lab management system

EpilepsyGTx appoints Professor Dimitri Kullmann as Chief Scientific Officer

Appointment of UCL Neurologist will accelerate the delivery of novel gene therapies for refractory epilepsy

Bio-Rad launches PTC Harmony 96 and PTC Harmony Deepwell Thermal Cyclers

New PTC Harmony Thermal Cycler Line Expands Access to Reliable, High-Performance PCR Across Academic and Biopharma Laboratories

PlaqueTec closes $5 million financing

Oversubscribed round backed by existing shareholders Investment will support development of cardiovascular disease database to be used to inform patient stratification and therapeutic development programmes

Cambridge, UK, 27 April 2026:

Atelerix launches STORganoid cryo-free preservation solution for complex 3D cell models

Ambient-temperature preservation solution enables reliable storage and shipment of organoids and spheroids, to support growing adoption of New Approach Methodologies 

Atelerix forms strategic partnership with JH Health Ltd to expand non-cryogenic cell preservation capabilities in the Middle East

Agreement grants JH Health exclusive rights to use and distribute Atelerix’s portfolio of non-cryogenic preservation solutions in the regionExpands regional capabilities with funding for high-volume local manufacturing, as well as relevant regulatory filings and researc

Bio-Rad extends range of anti-idiotypic antibodies and anti-Fc mutation antibodies for bioanalysis and drug monitoring

Expanded antibody portfolio enhances detection of biologics and YTE-modified therapeutics for bioanalytical applications

OBN rebrands to BioUK in alignment with its mission to catalyse success in UK life sciences

·        The new name reflects the national reach of the UK life science membership organisation and leverages its wide and long-established portfolio of Bio-prefixed events 

ProImmune collaborates with The University of Texas Medical Branch to Advance Infectious Disease Research

Development of novel Ankyrons will enable study of emerging high-consequence infectious diseases to inform vaccines and treatments

VALANX Biotech establishes Scientific Advisory Board to advance ADC therapeutics

John Lambert, Morris Rosenberg and Peter de Waele appointed as Chair and members of the SAB respectivelySAB provides scientific expertise and drug development experience, supporting advancement of the Company’s GoldenSite™ conjugation platform and its LIV-1 targeting le

SPT Labtech and EMBL GeneCore collaborate to advance fully walkaway automation in genomics workflows

firefly+ liquid handling platform installed at EMBL GeneCoreCollaboration to enable more streamlined end-to-end workflows while maintaining sample integrity

Cambridge, UK, and Heidelberg, Germany, 13 April 2026: SPT Labtech, a global le

FairJourney Bio opens Cryo-EM structural biology facility in San Diego

Antibody discovery expert expands presence in US biotech ecosystem with world-leading atomic-resolution structural biology capabilities

 

William Blair analysts name Carterra a winner in life science tools for enabling AI drug discovery at unprecedented scale

Carterra, with its HT-SPR technology platforms, is listed alongside large public companies as a technology provider to capitalize on the likely growth in wet lab work driven by the increasing use of AI in early discovery

Virica Biotech and FUJIFILM Biosciences Collaborate Under the Canada–Japan Co-Innovation Program to Advance AAV Production Enhancers

Efficient production of Adeno-Associated Virus (AAV) vectors at scale for in vivo gene therapies remains a key bottleneck for broad patient access and sustainable manufacturing costs 

PRISM ALS: New stem cell models could transform research into treatments for MND/ALS

PRISM ALS is a new global initiative designed to accelerate the discovery of effective treatments for ALS/MND by improving access to specially grown, patient-derived stem cell models that better reflect the biological diversity of the disease. The collaboration brings t

Broken String Biosciences rebrands to reflect strategic evolution as demand grows for unbiased genome-wide off-target analysis

Rebrand follows appointment of new leadership as company drives commercialization of INDUCE-seq platform to address regulatory gaps in off-target reporting for gene editing programs

iXCells Biotechnologies Joins International Collaboration to Evaluate Chemotherapeutic Toxicity in Human Organoids

Joint initiative with Rosebud Biosciences, Kantify, and funded by Incite will identify and quantify off-target toxicities in chemotherapy patientsDevelopment of patient-specific human organoids models for heart, liver, and kidney tissues

San Die